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The distributions of xanthine dehydrogenase (XD) and xan-
thine oxidase (XO) in subpopulations of murine keratino-
cytes differing in their stages of terminal differentiation were 
determined by enzymatic analyses. Keratinocytes were iso-
lated from the skins of female SEN CAR mice that had been 
treated 72 h earlier with either acetone or 12-0-tetradecan-
oylphorbol-13-acetate (TPA). The ratio of XO/(XD + 
XO) specific activities was used as an index of the XD to XO 
conversion. The XO/(XD + XO) ratios for basal cell, su-
prabasal cell, granular cell plus squamae, and horny sheet 
preparations isolated from acetone- or TPA-treated mice 
were 0.35, 0.35, 0.45, 0.75 and 0.28, 0.29, 0.58, and 1.0, 
respectively . Total XD + XO and XO specific activities in 
each subpopulation derived from TPA-treated mice were ap-
X anthine dehydrogenase (XD) and xanthine oxidase (XO) are purine catabolism enzymes that catalyze the conversions of hypoxanthine to xanthine and xanthine to uric acid. Whereas XD uses NAD+ as an oxidant, XO uses O 2 , which results in the produc-
tion of superoxide. 
We recently reported the presence of XD and XO in murine 
epidermis and their modulation by topically applied tumor pro-
moters [1,2] . Specifically, we noted that promoting doses of 12-0-
tetradecanoylphorbol-13-acetate (TPA) increased in vivo epidermal 
XO activity approximately twofold within 48 - 96 h of treatment. 
This increase was due to both de novo synthesis ofXD and conver-
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proximately twice the values measured in their control coun-
terparts. Suspension culturing of basal cell keratinocytes in 
methylcellulose induced terminal differentiation and a con-
version ofXD to XO. The kinetics of keratin disulfide cross-
linking and the XD to XO conversion were similar and 
preceded cornification. Collectively, these studies demon-
strate that the conversion of XD to XO occurs primarily 
during the later stages of keratinocyte terminal differentia-
tion. Furthermore, the increases in XO activity measured in 
epidermal homogenates after TPA treatment are due to 
TPA-dependent increases in 1) the relative proportions of 
keratinocytes undergoing differentiation, 2) tissue XD con-
tent, and 3) increased conversion ofXD to XO.] Invest Der-
matoI93:132-135, 1989 
sion of preexisting and newly synthesized XD to XO. The effects of 
TPA on epidermal XO activity were not promoter specific as hy-
perplastic, nontumor promoting agents also elevated XO activity 
[2]. Furthermore, agents that inhibited TPA-induced hyperplasia 
also prevented elevations in XD and XO activities [2] . These studies 
suggested that the elevations in XO activity and the conversion of 
XD to XO were associated with epidermal hyperplasia. DNA syn-
thesis and increases in keratinocyte number, however, preceded 
significant elevations in XO activity by at least 1 to 2 d. Conse-
quently, a certain amount of aging of preexisting and newly derived 
keratinocytes was required before measurable increases in XO activ-
ity were observed. 
One plausible explanation for the observed TPA effects on epi-
dermal XO activity, which is consistent with all of our preliminary 
studies, is that the XD to XO conversion may occur in differentiat-
ing keratinocytes. The overall percentage of keratinocytes under-
going differentiation markedly increases after TPA treatment [3-
6] . Indeed, the kinetics of the increase and decline of epidermal XO 
correlated with the relative percentage of differentiating keratino-
cytes in the epidermal fractions [1 ,4-6]. In the current study we 
used two approaches to assess directly whether the XD to XO 
conversion occurs in differentiating keratinocytes. First, we fol-
lowed the kinetics of conversion in basal cell keratinocyte prepara-
tions that had been induced to differentiate in vitro by suspension 
culturing in a semisolid medium [6,7] . Second, we took advantage 
of the findings that keratinocyte buoyant density decreases during 
terminal differentiation [6,8-11] and that subpopulations of pri-
mary cells differing in their stages of differentiation can be conve-
niently prepared by PERCOLL gradient centrifugation [6,8 -10]. 
Enzymatic analyses were made in the separated subpopulations. 
Using this approach we recently demonstrated a fivefold gradient of 
ca talase specific activities in murine epidermal subpopulations (12]. 
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MATERIALS AND METHODS 
Chemicals Hypoxanthine, xanthine, uric acid, and PERCOLL 
were purchased from the Sigma Chemical Company, St. Louis, 
MO. Radiolabeled [S-1 4C] hypoxanthine (50 - 53 mCi/mmole) 
was a product of Amersham, Arlington Heights, IL. DEAE cellulose 
thin-layer chromatography plates were obtained from the Eastman 
Kodak Company, Rochester, NY. TPA was purchased from Chem-
ica ls for Cancer Research, Inc., Eden Prairie, MN. 
Animal Treatment Protocols Female SEN CAR mice (7 - 9 wk 
old, National Cancer Institute, Frederick, MD) were used for all 
experiments. Mice were shaved 1 wk before treatment. Animals in 
hair regrowth were not used. The TP A (2 ,ug) was applied topically 
in 0.2 ml of acetone. 
Preparation of Epidermal Homogenates Mice were killed by 
cervical dislocation. The dorsal skin was excised and placed epi-
dermis side down on a glass plate that rested on ice. After removal of 
the fat pad from the dennis, the tissue was blotted, inverted, and 
scraped with a razor. Epithelial scrapings were suspended in 50 mM 
potassium phosphate, pH 7.S, 0.1 mM EDTA (4 °C) and homoge-
nized with a Brinkmann polytron (setting 4,30 s total). The result-
ing homogenate was centrifuged for 15 min at 13,500 g and the 
supernatant fluid recentrifuged for 5 min at 13,500 g. The resulting 
supernatant fluid was used immediately for XD and XO assays . 
PERCOLL Separation ofKeratinocytes Skin pelts free of fat 
pad were cut into small strips and floated dermis side down on 
0.25% trypsin [in phosphate-buffered saline (PBS)] for 1 h at 37°C 
followed by a 45-min incubation at room temperature. The epi-
dermis was scraped from the dermis, minced, and stirred at room 
temperature for 30 min in Eagle'S minimum essential medium. The 
resu lting cell suspension was fi ltered through nylon mesh to re-
move squamous sheets and centrifuged to pellet the cells. The squa-
mous sheets were washed twice with PBS before being processed as 
described below for PERCOLL separated keratinocytes. The pellet 
was washed once by resuspension - pelleting and finally resus-
pended in 50% PERCOLL (diluted in MEM). Keratinocytes were 
separated into subpopulations by centrifugation for 45 min at 
17,500 rpm in a Beckman Ti50 rotor at 4 ° C. Density marker beads 
were included in the gradients for calibration. Gradient fractions 
were pooled, diluted with PBS, and centrifuged to pellet the kerati-
nocytes. The resulting cell pellets were suspended in PBS, repel-
leted and resuspended in 0.25 - 0.5 ml of 50 mM potassium phos-
phate, pH 7.8, 0.1 mM EDTA. After homogenization (45 s, setting 
4, Brinkmann polytron, 4 ° C) the sample was centrifuged for 
15 min at 13,500 g. The resulting supernatant fluid was used imme-
diately for XD and XO assays. In a typical experiment 10-12 mice 
per treatment group were necessary to obtain sufficient cells for 
analyses. The entire PERCOLL procedure from the killing of mice 
through the homogenization of cells required approximately 5.5 h. 
Xanthine Dehydrogenase/Oxidase Assay Xanthine dehydro-
genase and oxidase were assayed by monitoring the conversion of 
radiolabeled hypoxanthine to xanthine and uric acid. Total XD + 
XO activity was measured in reaction mixtures (final volume 40 ,ul) 
containing 1 mM NAD+, 50 mM Tris-HCI, pH 9.0, 0.045 mM 
[8- 14C] hypoxanthine (50-53 mCi/mmole), and enzyme prepara-
tion. Oxidase activity was assayed similarly but in the absence of 
NAD+. Reactions were initiated by the addition of enzyme prepara-
tion and incubated for 10 min at 37°C. Reactions were terminated 
by the addition of 20,u1 of 1 M perchloric acid and centrifuged for 
2 min at 13,500 g. Five,ul of the supernatant fluid were spotted on 
cellulose thin-layer chromatography plates prespotted with 2.5Jtl 
of 10- 2 M solution of unlabeled hypoxanthine, xanthine, and uric 
acid. Thin-layer chromatogra~hy plates were developed with a 
CH3(CH2hCH20H/CH30H/H20/NH40H(25%)(60: 20: 20: 1) 
mixture and reference metabolites were located with an ultraviolet 
li ght. Areas of the thin-layer chromatography plates corresponding 
to xanthine and uric acid were excised and analyzed by liquid scin-
tillation counting. A reaction mixture containing no enzyme prep a-
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ration was processed in parallel as a control and subtracted from the 
experimental values. Specific activity is expressed as nanomoles of 
hypoxanthine oxidized to xanthine plus uric acid per min per mg 
protein. Protein content was determined with the Bio-Rad protein 
assay reagent using bovine serum albumin as a standard. 
Suspension Culturing ofKeratinocytes A modification of the 
procedure of Green [7], as described by Reiners and Siaga [6], was 
used for the culturing of keratinocytes in sen'lisolid medium. Basal 
cell keratinocytes prepared by PERCOLL gradient centrifugation 
were suspended in 0.5 ml of MEM and added to a cu lture tube 
containing 10 ml of methylcellulose medium (Methocel, Dow-
Corn ing, 4000 cps, 1.5 g/lOO ml). The cultures were maintained at 
37°C in a humidified 5% CO2 incubator. 
Terminal Differentiation Assay Terminal differentiation of 
sllspension cultured keratinocytes was monitored by measuring the 
fraction ofkeratinocytes that had formed disulfide cross-linked ker-
atin filaments and cornified envelopes. T he former are detected by 
their insolubility in 1 % sodium dodecylsulfate (SDS) and the latter 
by their insolubility in 1 % SDS and 1 mM dithiothreitol (DTT). 
The procedure we employed has been described in detail [6]. 
RESULTS 
Epidermal XD and XO Specific Activities Topical treatment 
of murine epidermis with a hyperplastic dose of TPA significantly 
elevated epidermal XO activity (Table I). Total XD + XO and XO 
specific activities 72 h after TP A treatment were 186% and 250%, 
respectively, of values measured in acetone-treated mice. The XO / 
(XD + XO) ratio in acetone-treated epidermis, which is an index of 
the XD to XO conversion, was less than the ratio measured in 
TPA-treated epidermis. 
XD and XO Activities in Keratinocyte Subpopulations We 
recently demonstrated that analyses of homogenates prepared from 
unfractionated epidermal scrapings reflect the activities of the pre-
dominate cell type [12]. Unless keratinocytes differing in their 
stages of differentiation have similar specific activities for any par-
ticular enzyme, analyses of unfractionated epidermal cell prepara-
tions may not be representative of the true range of activities within 
the epidermis. To address whether the XD to XO conversion 
occurs in differentiating cells, analyses were performed on keratino-
cytes that had been separated on PERCOLL gradients into popula-
tions whose stages of differentiation differed. The specific activities 
ofXD and XO measured in keratinocytes isolated from mice treated 
for 72 h with acetone or TP A are sllmmarized in Table I. Three 
trends are obvious. First, the specific activities of the various sub-
populations prepared by PERCOLL gradient centrifugation are less 
than the unfractionated epidermis . Comparable reductions, how-
ever, were measured in cells isolated from both acetone- and TPA-
treated mice. Second, the specific activities ofxO and XD + XO in 
all of the subpopulations prepared from TP A-treated mice are ap-
proximately one- to twofold greater than the activities of their 
control counterparts. Third, there is a gradient of XO and XD 
activities in the various subpopulations. The lowest XO activity was 
measured in the least differentiated keratinocyte fraction and the 
highest XO activity was measured in the horny cell layer. Con-
versely, if XD activity is calculated by subtracting XO activity from 
XD + XO activity, XD specific activity is greatest in the least dif-
ferentiated cell population and progressively decreases as the kerati-
nocytes differentiate. The inverse relationship between XD and 
XO in the cell fractions is best represented by the XO /(XD + XO) 
ratio. Specifically, the lowest XO/(XD + XO) ratio was measured 
in the least differentiated cell fraction and the highest ratio was 
measured in the horny cell fraction. Although a similar trend was 
seen in both control and TP A-treated mice, the gradient was most 
pronounced in mice treated with TPA. These results strongly sug-
gest that the XD to XO conversion occurs during keratinocyte 
differentiation. Furthermore, based on the cell types found in the 
various subpopulations, it appears that the conversioll occurs pri-
marily during the later stages of keratinocyte differentiation. 
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Table I. Characterization of XD and XO Activities in Murine Epidermis and Keratinocyte Subpopulations Differing in Their Stages 
of Terminal Differentiation" 
Keratinocyte 
Density XO XD+XO XO (%) (g/ml) Typeb Treatment (nmolc/min/mg)' (nmole/min/mg)' XD+XO 
Epidermis Acetone 1.79 ± 0.16 3.41 ± 0.28 52.6 ± 2.4 
Epidermis TPA 4.48 ± 0.40J 6.35 ± 0.56J 70.5 ± 1.1 J 
Horny sheet Squamae Acetone 1.11 ± 0.03 1.49 ± 0.04 74.8 
,,; 1.048 Granular, squamae Acetone 0.49 ± 0.05 1.09 ± 0.11 44.9 
1.048 -1.060 Spinous Acetone 0.71 ± 0.06 1.97±0.18 34.8 
1.060 -1.083 Spinous Acetone 0.66 ± 0.07 1.98 ± 0.17 35.6 
2: 1.083 Basallike Acetone 0.65 ± 0.09 1.64 ± 0.22 34.9 
Horny sheet Squamae TPA 2.58 ± 0.19' 2.S7±0.19J 102.6 
,,; 1.048 Granular, squamae TPA 1.29 ± 0.19J 3.07 ± 0.06J 58.2 
1.048 - 1.060 Spinous TPA 1.16 ± 0.16' 3.80 ± 0.47J 30.8 
1.060- 1.083 Spinous TPA 1.21 ± 0.09J 3.98 ± 0.34J 29.3 
2: 1.083 Basallike TPA 1.10 ± 0.08' 3.98 ± 0.45J 28.1 
• Epidermal homogenates and keratinocyte subpopulations were prepared from the dorsal skins of mice treated 72 h previously with either 0.2 ml acetone or 2/lg TPA dissolved in 
acetone. Subpopulations were prepared by PERCOLL gradient centrifugation. 
I The criteria for cel l type designations have been previously published [12]. Debris, squamae, and granular cells collectively contributed less than O.S% and 10% of the material in 
subpopulations with densities 2: 1.06 g/ml and 1.048-1.06 g/ml, respectively. Keratinocyte preparations with densities :5 1.048 g/ml contained less than S% spinous cells. 
, Specific activities ofxO and XD + XO. Epidermal values represent the mean ± SE of two experiments each employing 3 mice pet treatment. Keratinocyte subpopulation values 
represent the mean ± SE of five experiments. 
J Significantly different from acetone control counterpart (p <O.OOS by Student's I-test) . 
' Significan tl y different from acetone control counterpart (p < O.OS by Student's I-test). 
In Vitro Conversion ofKeratinocyte XD to XO Suspension 
culturing of basal cell keratinocytes in a semisolid medium induces 
terminal differentiation [6,7]. The biochemical changes that occur 
in suspension cultured keratinocytes mimic those that occur in vivo. 
Two convenient markers for the later stages of differentiation are 
formation of disulfide cross-linked keratins and the cornified enve-
lope [6,7 ,11 ]. Cells with keratins that are disulfide cross-linked are 
insoluble in SDS but soluble in SDS plus DTT. Conversely, cells 
having formed cornified envelopes are insoluble in SDS plus DTT. 
Table II demonstrates that basal cell preparations of normal mice are 
soluble in SDS alone at the time of isolation, but become increas-
ingly insoluble in SOS upon being suspension cultured. Similarly, 
XD converts to XO on suspension culturing. The kinetics of kera-
tin disulfide cross-linking and the XD to XO conversion were 
similar and considerably faster than the formation of cornified en-
velopes. 
DISCUSSION 
The current study suggests that the conversion of XD to XO pri-
marily occurs in keratinocytes undergoing terminal differentiation. 
The XO/(XD + XO) ratios of basal and spinous cells were similar 
and less than the ratios measured in granular cell preparations, 
which in turn were less than the values measured in squamous cells. 
Although we consistently measured XO/(XD + XO) values vary-
ing between 0.28 and 0.35 for our basal cell preparations, these 
values may actually be high for true basal cells. Recent studies by 
Klein-Szanto et al [9] suggest that our basal cell preparations consist 
of both true basal cells and keratinocytes committed to differentia-
tion. Indeed, when our PERCOLL isolated basal cell preparation is 
plated, only a small percentage of the cells attach, and the XO/ 
(XD + XO) ratio of the attached cells is approximately 0.15. Con-
sequently, the in vivo XO/(XD + XO) gradient may be more pro-
nounced than we measured, Based on the XO/(XD + XO) ratios 
and morphologies of the PERCOLL isolated keratinocytes, it ap:" 
pears that the XD to XO conversion predominantly occurs in cells 
undergoing the final stages of differentiation. Because of cross-con-
tamination of the granular cell preparations with squamae, and vice 
versa, it is uncl ear whether the XD to XO conversion is initiated in 
granu lar cells, occurs during the transition of granular cells to squa-
mae, or occurs during the maturation of squamae. The in vitro 
suspension culture studies, however, suggest that XD to XO con-
version precedes cornified envelope formation. 
The XD to XO conversion can be mediated in vitro by either 
limited proteolysis or oxidation of sulf11ydryl residues on XD 
[13,14]. Keratinocyte terminal differentiation is characterized by 
dramatic changes in the oxidation-reduction potential of the cell. 
The formation of keratin disulfide cross-links during keratinocyte 
differentiation is thought to be a consequence of the emergence of 
an oxidizing environment [7] . An environment that mediates the 
oxidation of keratin sulfhydryls should also faci litate the oxidation 
of sulfhydryls on XD, and the conversion ofXD to XO. Indeed, the 
kinetics of keratin disulfide cross-linking and the XD to XO con-
version in suspension cultured keratinocytes were very similiar. 
Conversely, organelle destruction is a late event in the keratinocyte 
terminal differentiation program and is mediated by proteases 
[1 5,16]. The marked conversion of XD to XO in squamous cell 
preparations is consistent with the conversion being mediated by 
proteases. We have recently published enzymatic studies that sup-
port the existence of both proteolytic- and nonproteolytic-derived 
XO in the scrapings of normal and TPA-treated epidermis [1]. 
Future studies are directed at determining the distribution of the 
XO types in the keratinocyte subpopulations. 
The conversion ofXD to XO has been implicated in the pathol-
ogy of ischemia [17], ethanol-associated myocardial [18,19] and 
hepatic toxicity [18], and interferon-induced lipoperoxidation [20]. 
The abilities of antioxidants to inhibit the cytotoxic effects of eth-
anol [21] suggest that it is the superoxide produced by XO, or the 
reduced forms of superoxide (hydrogen peroxide, hydroxyl radical), 
that mediate the toxicity. Numerous studies implicate the involve-
Table II. Kinetics of XD to XO Conversion in Suspension-
Cultured Keratinocytes 
Cu lture XO 0 
% Cells Resistant to: 
Time (h) XD + XO(Vo) SDS SDS+DTT 
0 32.4 0 0 
23 75.5 40 2 
47 79.6 97 23 
Murine keratinocytes prepared by the trypsin-flotation procedure were separated into 
subpopulations by PERCOLL gradient centrifugation. Keratinocytcs with densities 
> 1.060 g/ml were pooled. A portion of this cell preparation wassplit off for analyses (0 
time) and the remai nder suspension-cultured in methylcellulose. Samples were with-
drawn at indicated times for ana lyses. Cel ls resistant to solubilization by SDS or 
SDS + OTT represent cel ls having formed disulfide cross-linked kerati ns and cornified 
envelopes, respectively. 
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ment of superoxide and hydrogen peroxide in TPA promotion 
[22,23]. Topical treatment of murine epidermis with TPA dimin-
ishes the specific activities of enzymes (superoxide dismutase, cata-
lase, glutathione peroxidase) involved in superoxide and hydrogen 
peroxide detoxification [12,24 - 27]. These decreases in detoxifying 
enzymes, coupled with an increase in XO activity, might lead to 
increased cellular levels of hydrogen peroxide in TPA-treated epi-
dermis. Indeed, Robertson et al [28] recently reported a 50% in-
crease in the cellular H 2021eveis ofkeratinocytes derived from mice 
treated in vivo with TP A. 
Relative to normal epidermis , topical treatment with TPA in-
creased overall XO activity and the XO/(XD + XO) ratio mea-
sured in homogenates of epidermal scrapings. The current study 
provides a bases for the TP A effects. There appear to be two factors 
that contribute to the effects ofTPAon the XO/(XD + XO) ratio. 
The first factor relates to the composition of the epidermis after 
TP A treatment. Maximum XO activity in epidermal scrapings is 
detected at a time (48 - 96 h post-TPA treatment) during which a 
majority of the epidermis consists of differentiating keratinocytes 
[1,3- 6]. Because the XO/(XD + XO) ratio is greatest in differen-
tiating keratinocytes it follows that the ratio would be greater in 
TPA-treated epidermis, relative to normal epidermis. The second 
factor relevant to the elevated XO/(XD + XO) ratio in TPA epi-
dermis entails enhanced conversion of XD to XO. Specifically, 
whereas 100% of the dehydrogenase had converted into oxidase in 
squamous fractions derived from TPA-treated mice, only a 75% 
conversion was detected in comparable keratinocytes isolated from 
control mice. The basis for the enhanced conversion ofXD to XO 
in TPA-treated epidermis is unknown. However, it may be related 
to the TPA-dependent induction of proteases [29]' depletion of 
reduced glutathione [24,25]' and reductions of epidermal superox-
ide dismutase [26], catalase [1 2,26,27], and glutathione peroxidase 
[24,25] activities. The induction of proteases might facilitate the 
proteolytic conversion ofXD to XO; whereas the latter two situa-
tions would favor the creation of an oxidizing environment that 
would support the oxidation of sulfhydryls on XD. The relative 
increases in total XO specific activity in TPA-treated epidermis, 
compared with normal epidermis, are dependent on the aforemen-
tioned effects on the XO/(XD + XO) ratio and the TPA-depen-
dent induction of XD synthesis. Previous studies using cyclohexi-
mide demonstrated that XD synthesis is induced in murine 
epidermis by TPA treatment [1]. The specific activities of XD in 
each of the keratinocyte subpopulations prepared from TP A-treated 
mice were approximately double the values of their control coun-
terparts. Consequently, increases in total XD content coupled with 
increased conversion of XD to XO could account for the overall 
increases in XO activity in TPA-treated epidermis. 
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